Literature DB >> 20149322

Tenofovir-induced osteomalacia.

D P Wanner1, A Tyndall, U A Walker.   

Abstract

We present an HIV-infected woman in whom antiretroviral treatment with tenofovir disoproxil fumarate (TDF) induced severe skeletal pain, synovial effusions and multiple fractures secondary to a Fanconi syndrome with hypophosphatemia and osteomalacia. TDF interferes with the replication of mitochondrial DNA in the proximal tubules of the kidney, which can explain the delayed onset of this form of renal phosphate loss. Nephrotoxicity had been precipitated by cotreatment with lopinavir/r, an HIV protease inhibitor which increases tenofovir serum levels and inhibits the tubular multidrug resistance protein 4, which is responsible for the efflux of tenofovir from tubular cells.Awareness is needed to link the typically prolonged onset of clinical symptoms with TDF exposure and then establish the correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20149322

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  12 in total

1.  Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients.

Authors:  Lourdes Mateo; Susana Holgado; Maria Luisa Mariñoso; Ricard Pérez-Andrés; Anna Bonjoch; Joan Romeu; Alejandro Olivé
Journal:  Clin Rheumatol       Date:  2014-05-03       Impact factor: 2.980

2.  Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens.

Authors:  Todd T Brown; Allison C Ross; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  Antivir Ther       Date:  2011

3.  Bilateral sub-trochanteric femur fragility fractures in a patient on antiretroviral therapy: a case based discussion and review of literature.

Authors:  Rajesh K Rajnish; Pratik M Rathod; Sameer Aggarwal; Saurabh Agarwal; Prasoon Kumar
Journal:  Int J Burns Trauma       Date:  2020-08-15

Review 4.  Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS.

Authors:  Rene F Chun; Nancy Q Liu; T Lee; Joan I Schall; Michelle R Denburg; Richard M Rutstein; John S Adams; Babette S Zemel; Virginia A Stallings; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2014-08-01       Impact factor: 4.292

5.  Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.

Authors:  T Porcelli; D Gotti; A Cristiano; F Maffezzoni; G Mazziotti; E Focà; F Castelli; A Giustina; E Quiros-Roldan
Journal:  Osteoporos Int       Date:  2014-07-24       Impact factor: 4.507

6.  Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV.

Authors:  Julie M Lucey; Peter Hsu; John B Ziegler
Journal:  BMJ Case Rep       Date:  2013-07-09

7.  Nephrotoxicity of HAART.

Authors:  Robert Kalyesubula; Mark A Perazella
Journal:  AIDS Res Treat       Date:  2011-08-15

8.  Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.

Authors:  Arash A Horizon; Robert J Joseph; Qiming Liao; Steven T Ross; Gary E Pakes
Journal:  HIV AIDS (Auckl)       Date:  2011-06-28

9.  Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.

Authors:  Sana Waheed; Doaa Attia; Michelle M Estrella; Yousuf Zafar; Mohamed G Atta; Gregory M Lucas; Derek M Fine
Journal:  Clin Kidney J       Date:  2015-06-03

Review 10.  The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.

Authors:  M Neale Weitzmann
Journal:  Scientifica (Cairo)       Date:  2013-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.